11 | MD Anderson Cancer Center

More than half of patients alive two years after receiving CAR-T...

December 02, 2018

A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma (DLBCL) reported 51...

MD Anderson, Houston Dynamo team up for one goal: end cancer

BY Rolaynne Kimmons

November 28, 2018

The University of Texas MD Anderson Cancer Center and the Houston Dynamo today announced plans to work together toward one goal: end...

Peers choose MD Anderson’s Gershenwald, Hwu as new AAAS...

BY Rolaynne Kimmons

November 27, 2018

Two leaders in the field of melanoma treatment – a surgeon and an oncologist – from The University of Texas MD Anderson Cancer Center...

Stand Up to Cancer funds innovative approach to pancreatic cancer

November 20, 2018

Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far...

Investigational drug shows promising results in Phase II...

BY Rolaynne Kimmons

November 14, 2018

A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer Center, reports an investigational drug called...

Immunotherapy combination and chemotherapy show encouraging...

BY Rolaynne Kimmons

November 13, 2018

A triple therapy combining two immune checkpoint inhibitors (ICPIs) with the standard-of-care chemotherapy, a hypomethylating agent...

First UT System clinical collaboration launches between MD...

BY Rolaynne Kimmons

November 12, 2018

The University of Texas MD Anderson Cancer Center today formally opened a four-story facility in League City that houses new and...

Newsroom

November 2018 Archive

More than half of patients alive two years after receiving CAR-T...

MD Anderson, Houston Dynamo team up for one goal: end cancer

Peers choose MD Anderson’s Gershenwald, Hwu as new AAAS...

Stand Up to Cancer funds innovative approach to pancreatic cancer

Investigational drug shows promising results in Phase II...

Immunotherapy combination and chemotherapy show encouraging...

First UT System clinical collaboration launches between MD...

Help #EndCancer

Newsroom

November 2018 Archive

More than half of patients alive two years after receiving CAR-T...

MD Anderson, Houston Dynamo team up for one goal: end cancer

Peers choose MD Anderson’s Gershenwald, Hwu as new AAAS...

Stand Up to Cancer funds innovative approach to pancreatic cancer

Investigational drug shows promising results in Phase II...

Immunotherapy combination and chemotherapy show encouraging...

First UT System clinical collaboration launches between MD...

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson